Literature DB >> 2939688

Importance of the interaction of midazolam and cimetidine.

M Salonen, E Aantaa, L Aaltonen, J Kanto.   

Abstract

Six healthy volunteers were given in an open study 15 mg of midazolam orally, and a couple of weeks later the same treatment preceded by 400 mg of cimetidine orally. We followed midazolam serum concentrations and the following pharmacodynamic parameters for five hours: subjective sedation, Maddox wing readings, critical flicker fusion frequency and peak velocity of saccadic eye movements. A statistically significant change was found in Cmax and total AUC between the two sessions. The pharmacodynamic responses differed also clearly from each other suggesting a significant change in midazolam effect even after a single oral dose of cimetidine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939688     DOI: 10.1111/j.1600-0773.1986.tb00076.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  5 in total

Review 1.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

Review 2.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 3.  Pharmacokinetics of the newer benzodiazepines.

Authors:  P D Garzone; P D Kroboth
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

4.  The effect of cimetidine on the single dose pharmacokinetics of oral clobazam and N-desmethylclobazam.

Authors:  T Pullar; D Edwards; J R Haigh; S Peaker; M P Feely
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

5.  Difference in action between oral triazolam and zopiclone.

Authors:  R Aantaa; M Salonen; T Nyrke
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.